Aclarion, Inc. Common Stock (ACON) Stock Price
ACONStock
$1.85−78.74%52W
Market Cap$5.33M
P/E—
PEG Ratio—
Div yield—
Beta1.26
ACON Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-51.55%
Price vs S&P 500 (4W)-23.47%
VGM Score42.02
ACON Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$1.05 | -$1.12 | -6.67%(-$0.07) | |
| Q1 2026 | -$1.55 | -$1.34 | +13.55%(+$0.21) | |
| Q4 2025 | -$3.60 | -$4.52 | -25.55%(-$0.92) | |
| Q3 2025 | -$2.64 | -$2.93 | -10.98%(-$0.29) | |
| Q2 2025 | -$2.26 | -$2.75 | -21.63%(-$0.49) |
ACON Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.14
4.14
4.14
4.14
Industry Peers — Health Services(30)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
ACONAclarion, Inc. Common Stock | — | B | F | — | 33.1% | -11592.2% | -59.3% | $1.85 |
| NTRANatera, Inc. Common Stock | F | A | A | — | 37.8% | -10.7% | -11.7% | $393.44 |
| DGXQuest Diagnostics Inc. | C | D | B | 26.1x | 9.9% | 14.1% | 14.5% | $235.00 |
| LHLabcorp Holdings Inc. | C | D | B | 29.4x | 6.4% | 10.4% | 11.6% | $317.95 |
| GHGuardant Health, Inc. Common Stock | F | A | B | — | 42.7% | -40.2% | -246.6% | $158.60 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | B | — | 38.5% | 12.7% | 18.8% | $30.56 |
| RDNTRadNet, Inc. Common Stock | D | C | C | 1779.3x | 18.9% | 3.0% | -1.9% | $68.80 |
| GRALGRAIL, Inc. Common Stock | D | B | B | — | 23.1% | -338.4% | -15.9% | $117.81 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | C | 621.1x | — | 10.9% | 8.9% | $98.12 |
| VCYTVeracyte, Inc. | D | B | C | 52.2x | 17.3% | 19.6% | 8.6% | $43.12 |
| CDNACareDx, Inc. | D | B | A | 18.3x | 34.4% | 23.6% | 32.8% | $64.00 |
About Aclarion, Inc. Common Stock
Aclarion Inc provides Nociscan, a SaaS diagnostic platform that uses proprietary Magnetic Resonance Spectroscopy technology to help physicians noninvasively identify painful spinal discs. The company generates revenue by delivering diagnostic reports to medical professionals in the United States.